MediPharm Labs Corp. ( MEDIF) - Stock Earnings
MEDIF Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 12, 2026, midnight | — / — | — | — / — | — |
MEDIF Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | — USD | 12.2 million USD |
| 2025Q4 | — USD | 11.1 million USD |
| 2026Q1 | — USD | 9.0 million USD |
| 2026Q4 Est. | — | — |
MEDIF Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -17.4 million USD | 33.1 million USD |
| 2024 | — USD | 42.0 million USD |
| 2025 | — USD | 45.1 million USD |
| 2026 Est. | — | — |
MEDIF
Price: $0.05
52 week price:
Earnings Per Share: -0.03 USD
P/E Ratio: -1.83
Exchange: OQB
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 22.5 million